Highlights and Quick Summary
- Share Based Compensation of Revenue for the quarter ending September 30, 2022 was 140.57% (a 8.48% increase compared to previous quarter)
- Year-over-year quarterly Share Based Compensation of Revenue increased by 363.01%
- Annual Share Based Compensation of Revenue for 2021 was 84.04% (a -99.87% decrease from previous year)
- Annual Share Based Compensation of Revenue for 2020 was 64083.33% (a 64.13% increase from previous year)
- Annual Share Based Compensation of Revenue for 2019 was 39044.44% (a Infinity% increase from previous year)
- Twelve month Share Based Compensation of Revenue ending September 30, 2022 was 84.09% (a -5.0% decrease compared to previous quarter)
- Twelve month trailing Share Based Compensation of Revenue increased by 0.06% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 84.09% | 88.52% | 94.5% | 84.04% |
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Share Based Compensation of Revenue of Beam Therapeutics Inc.
Most recent Share Based Compensation of Revenueof BEAM including historical data for past 10 years.Interactive Chart of Share Based Compensation of Revenue of Beam Therapeutics Inc.
Beam Therapeutics Inc. Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 140.57% | 129.58% | 213.89% | – |
| 2021 | 30.36% | 1699.61% | 174200.0% | 77466.67% | 84.04% |
| 2020 | 113450.0% | 50200.0% | 46150.0% | 46533.33% | 64083.33% |
| 2019 | 34283.33% | 33816.67% | 34550.0% | 0.0% | 39044.44% |
| 2018 | – | – | – | – | 0.0% |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology